Skip to main content

Table 3 Antenatal surveillance. Values are n (%)

From: An evaluation of the influence of the publication of the UK National Institute for health and Care Excellence’s guidance on hypertension in pregnancy: a retrospective analysis of clinical practice

 

NICE hypertension in pregnancy recommendations

P-valuea

P-valueb (CI)

Before guidance N = 1271

After guidance N = 1219

Blood pressure recorded at every antenatal visit

962 (76)

913 (75)

0.60

0.56 (−0.04, 0.02)

If not recorded at every visit how often omitted:

N = 309

N = 306

0.30

 

 once

217 (71)

199 (65)

0.11 (−0.14, 0.01)

 twice

61 (20)

64 (21)

0.77 (−0.05, 0.07)

 three

16 (5)

30 (10)

0.02 (0.01, 0.09)

 four

9 (3)

7 (2)

0.43 (−0.03, 0.01)

  ≥ Five times

5 (2)

5 (2)

1.00 (−0.02, 0.02)

 

N = 1271

N = 1219

  

Proteinuria recorded at every antenatal visit

441 (35)

417 (34)

0.80

0.56 (−0.05, 0.03)

If not recorded at every antenatal visit how often omitted:

N = 830

N = 802

0.03

 

 once

341 (41)

315 (39)

0.41 (−0.07, 0.03)

 twice

246 (30)

195 (24)

< 0.01 (−0.10, − 0.02)

 three

126 (15)

147 (18)

0.10 (−0.01, 0.07)

 four

64 (6)

73 (9)

0.02 (0.00, 0.06)

  ≥ Five times

53 (6)

70 (9)

0.02 (0.00, 0.06)

  1. adifference in frequencies ‘before and after ‘guidance publication
  2. bdifference in proportions ‘before and after ‘guidance publication